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                Analisis Pengekspresan Antigen IBMR3 pada sel dan tisu dari rodensia 
                              
                                                         ABSTRAK 
 
Antibodi monoklonal (mab) dan pecahannya telah digunakan secara meluas untuk tujuan 
diagnostic dan terapeutik. Sel hibridoma IBMR3 telah dihasilkan dari kajian terdahulu. 
Supernatan sel kultur bagi sel hibridoma telah dikumpul dan disimpan pada suhu -20ºC.        
Matlamat projek ini adalah untuk mengkaji profil ekspresi antigen IBMR3 di dalam tisu 
mencit dan tikus, sel-sel HT29 dan 3T3 dengan menggunakan kaedah immunoblotting dan 
perwarnaan immunohistokimia menggunakan kaedah peroksida. Di dalam kajian ini 
pengekspresan antigen IBMR3 telah dinilai di dalam 80 organ yang berbeza dari mencit 
Balb/c dan tikus Sprague Dawley. Sel-sel yang telah dikenalpasti, sel kanser kolorektal 
manusia HT29 dan fibroblast 3T3. Tisu ini kemudian di laisiskan dengan penimbal laisis 
dan kepekatan laisis yang sama turut dijalankan pada 12% SDS-PAGE. Jalur protin yang 
terpisah, dipindahkan ke membran PVDF/Polivinildin diflorida untuk immunobloting. 
Hasil immunoblot telah dibuat analisis densitometrik untuk menentukan berat molekul, 
puncak ketinggian dan isipadu mentah untuk setiap protin. IBMR3Ag telah menunjukkan 
ekspresi di dalam tisu-tisu mencit dengan berat molekul yang paling tinggi (98.22 kDa) dan 
bilangan jalur protin yang paling banyak dikesan di dalam otot dan paling rendah di dalam 
jantung (75 kDa) dan hati (78.68 kDa). Di dalam tikus, lebih banyak jalur protin dikesan di 
dalam otak dan ginjal manakala hanya 4 jalur protin dikesan di dalam limpa. Berat molekul 
yang paling tinggi dikenalpasti di dalam otak (120.83 kDa) ginjal (85.48 kDa) dan limpa 
(73.42 kDa). Ekpresi antigen IBMR3 paling tinggi didapati di dalam paru-paru dan ekspresi 
paling rendah di dalam otak untuk kedua-dua mencit dan tikus. Kaedah pewarnaan 
xx 
 
immonohistokimia dengan teknik peroksida telah digunakan untuk mengkaji profil ekspresi 
antigen IBMR3 di dalam cebisan tisu-tisu beku yang berbeza bagi mencit dan tikus. 
IBMR3 Ag yang positif  boleh diperhatikan di bawah mikroskop bercahaya sebagai perang 
cair dan berubah berdasarkan kepekatannya samada lemah, sederhana dan legap. Ekspresi 
IMBR3 Ag membantu menganalisa profil bagi berat molekul, puncak ketinggian dan 
isipadu mentah. Keputusan ekspresi positif berbeza di antara kaedah immunobloting dan 
pewarnaan immunohistokimia untuk IBMR3 Ag di dalam bahagian tisu yang berbeza, 
membantu menentukan tahap antigen IBMR3 terhadap parameter patologi. Keputusan 
kajian ini menjelaskan bahawa antigen IBMR3 telah memberikan ekspresi yang berbeza di 
dalam tisu mencit, tikus dan sel. Kajian seterusnya akan dicadangkan pada masa hadapan 
untuk mengenalpasti dan mengkaji keadaan tindakan semulajadi antigen IBMR3 dan 
potensinya di dalam perjalanan pembangunan tisu. 
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ANALYSIS OF THE EXPRESSION OF IBMR3 ANTIGEN IN CELLS AND 
TISSUES FROMRODENTS 
                                                           ABSTRACT 
 
         Monoclonal antibodies (Mab) and their fragments have been widely used for 
diagnostic and therapeutic purposes. IBMR3 hybridoma cells were produced in a previous 
study. The cell culture supernatant of the hybridoma cells was collected and stored at -20 
°C freezer. The aim of this research is to investigate the expression profile of the IBMR3 
antigens in different tissue of mouse, rat and cell lines HT29, 3T3 by using immunoblotting 
technique and immunohistochemical staining using the peroxidase technique. In this study 
the expression of IBMR3 antigen was evaluated in eighteen different organs taken from 
Balb/c mouse and Sprague Dawley rat, established cell lines, human colorectal HT29 
cancer cell line and mouse fibroblast 3T3. Various mouse and rat tissues were snap- frozen 
and stored in liquid nitrogen. For immunoblotting six micron frozen sections of the various 
tissues were prepared and collected in Eppendorf tubes. The sections were then lysed in 
lysis buffer, and equal concentrations of lysates were run on 12% SDS-PAGE. The 
separated protein bands were transferred to PVDF/ polyvinylidene difluoride membrane for 
immunoblotting. Immunoblotting were subsequently subjected to densitometric analysis to 
get the value of molecular weight, peak height and raw volume of the protein band 
(Burnette, 1981). IBMR3Ag was expressed in mouse tissues with the highest MW (98.22) 
kDa and highest number (nine) of bands detected in muscle and the lowest MW in heart 
(75.00) kDa and liver (78.68) kDa with lowest number (2) of bands. In rat, more bands 
(eight) were detected in brain and kidney. While in spleen only four protein   bands were 
detected. The highest MW was also indicated in brain (120.83 kDa), kidney (85.48 kDa) 
xxii 
 
and 73.42 kDa in spleen. In both mouse and rat, highest expression of IBMR3 antigen was 
found in the lung and lowest in the brain. The immunohistochemical staining method was 
used in peroxidase technique for the investigation of the expression profile of the IBMR3 
antigens in different frozen tissues from mouse and rat. The positive IBMR3 antigen were 
seen under light microscope as brown color, the results between weak, moderate and 
intense. Expressed IBMR3 antigens help to analyze the profile for molecular weight, peak 
height and raw volume. The different results in immunoblotting and immunohistochemistry 
staining gave positive expression for IBMR3 Ag in different part of the tissue sections, this 
shed more light on, whether the level of IBMR3 antigens are associated with pathological 
parameters. The results from this study suggest that the IBMR3 antigens were differentially 
expressed in mouse, rat tissue and cell lines. It was recommended that further research be 
conducted to identify and investigate the nature of the IBMR3 antigen and its potential role 
in tissue development. 
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                                                       CHAPTER 1 
                                                   INTRODUCTION 
 
1.1 Monoclonal antibody 
The uses of monoclonal antibodies (Mabs) have been accepted for diagnosis and 
therapeutic medical indications, especially in oncology (Van Dongen et al., 2007: 
Abouzied et al., 1993; Cheung et al., 2002; Emanuel et al., 2000). Monoclonal 
antibodies can be used for the diagnosis of a specific antigen protein in a cancer cell 
line, normal cell line, normal or cancerous organs, bacteria, virus, parasite, food and 
blood. There are several types of methods for such studies like immunohistochemistry, 
immunoblotting and blot assay. 
The expression can be seen by the use of a labeled antibody with radioactive 
element, colloidal gold, fluorescent dye or enzyme. Therapies based on treatment with 
antibodies are being extensively investigated in several clinical trials during the past 
few years. Monoclonal antibodies can be generated against most target antigens, 
purified and split into fragments. Monoclonal antibody (Mabs) has the ability to 
conjugate with radio nuclides, toxins, enzymes or drugs.  
Such methods are used in laboratories for common techniques in many medical 
research and diagnostics (Hawkins et al., 1992). Mabs are preferred to be used in 
western blot, ELISA, immunohistochemistry, cell sorting (cell isolation) by (FACS) 
Fluorescent-activated cell sorting, cell depletion, confocal microscopy, protein 
purification and Imaging because of lower background interference. 
By nature, Mabs originate from one specific clone with higher specificity, 
purity, consistency and attractive for one epitope of the antigen. However, these 
antibodies require secondary antibodies which are “prepared to measure” both single 
 
 
2 
 
and simultaneous measurement of multiple analyses (Spinks, 2000). The expression of 
IBMR3 in different organs and in cancer cell line encouraged to be employed as a future  
strong marker in diagnosis of cancerous diseases. 
  
1.2 IBMR3 
1.2.1 Introduction of IBMR3 Ag 
Monoclonal antibody (Mab) is a single type of antibody. Cell line fusion 
between stimulated B-cell with myeloma cell which produce hybridoma cell is shown in 
Figure 1-1. The monoclonal antibody then will produce by cloning of a single 
hybridoma or single parent cell line; sometimes naturally, myeloma cells produce single 
Mab (Hawkins et al., 1992).  
 
   
Figure 1.1: False color scanning electron micrograph of hybridoma cells used to 
produce monoclonal antibodies for treating cancer (Hawkins, et al., 1992) 
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IBMR3 is a monoclonal antibody, IgM isotype, produced by Ishak Mat in mice (Hara 
and Mat, 2004). Many antibodies have been raised using synthetic peptides 
corresponding to selected amino acid sequence for protein encoded by various genes 
(Walter and Doolittle., 1983). One of the attractive results of using this approach is that 
antibodies raised may cross react with native proteins (Mat, 1992). In another study 
generated mouse Mab IBMR3, of IgM isotype, using synthetic peptides corresponding   
to selected amino acid sequences of the (HIL-4R) human interleukin 4 receptor 
molecules, (Galizzi et al., 1990). Because of mammalian IL-4 receptor proteins.  
            Previously it was shown that Mab IBMR3 does not block IL-4 (Mat, 1992).  On 
the other hand Mab IBMR3 showed recognition and binding with relative molecular 
mass of 100 KD and 50 KD with minor affiliation at 200KD (Mat,1992). Mab IBMR3 
was used to analyze the expression of IBMR3Ag in normal (PBMC) peripheral blood 
mononuclear cells, established cell lines, AML (acute mylogenous leukemia) and ALL 
(acute lymphoblastic leukemia), after analysis by flow cytometry and immunoblotting 
techniques. The results showed a weak response in resting PBMCs on surface staining 
with high cytoplasmic levels of the antigens. Similar expression in ALL and AML were 
observed except that of the AML two samples since they showed surface expression 
while all of the ALL-B and ALL-T specimens were non- reactive (Hara and Mat, 2004). 
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  1.3 Expression patterns / significance of IBMR3 Ag 
          Flowcytometry results suggest that the IBMR3 antigens are mostly indicated in 
the cytoplasm rather than on the cell surface. IBMR3 Ag has shown different expression 
in different cells. However, surface expression may occur in certain type of cells as seen 
in two cases of AML (Acute Mylogenous leukemia). Immunoblotting analysis suggests 
that IBMR3 Ag expression on the cell surface is inducible.  
          They showed that although all cells expressed the IBMR3 Ag, some cells differed 
in their expression. For example HepG2 did not express the 230kDa molecule but 
45kDa molecules can express.  
          The nature of the Ag recognized by Mab IBMR3 has not been determined and the 
significance of this observation is not known. Nevertheless, Mab IBMR3 might 
recognize the same epitope which is shared by molecules having different molecular 
masses (Hara and Mat, 2004). Mab IBMR3 may be useful to identify and study the roles 
of these molecules in normal and transformed cells. These results suggest the possible 
association of up regulated IBMR3 Ag expression in malignant cells and cells with 
poorly differentiated morphology. From these studies one can speculate that IBMR3 Ag 
might have a role in tumor development and that its expression pattern may have a 
significant value in cancer prognosis (Hara and Mat, 2004). 
 
1.4 Antibody  
1.4.1 Characteristics of a good antibody 
         The main requirement for a good antibody is that it should have high affinity for 
its antigen.  Generally, antibodies are classified into three groups; IgM, IgG and IgA. 
Their concentration, specificity and isotype can affect or rather determine the action of 
an Ab. (Casadevall and Pirofski, 2003). Antibodies connect with specific antigens at 
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suitable sites and not with other unrelated antigens. The attachment site, commonly 
known as fitting site, establishes the strength of connection between antibody and 
antigen (Roitt et al., 2006). Antibody applied in (IHC) immunohistochemistry as much 
as immunocytochemistry and it is applied in histopathology and cell biology (Gatter et 
al., 1985). The fragments of antibodies can interact with the amino acids on the cell 
which form antigen (molecules) or binding site of the antibody. 
 
1.5 New concepts in antibody-mediated immunity 
The immuno regulatory properties of antibody have been known since the 
beginning of passive immunization experiments. The development of the field of 
immunology started in the beginning of 20th century. 
The functional aspects of antibody-mediated immunity (AMI) stagnated in the 
1960s. The potential to adjust an immune response to immunize antibody with 
binding site has been established more than ten years ago (Antoniou and Watts, 2002; 
Rafiq et al., 2002; Rhodin et al., 2004). After knowing the function of antibodies, the 
available Abs preparations were limited to polyclonal immune sera.  The discovery of T 
cells helped to improve T cell-mediated immunity.  
At the end of 1980s the development of monoclonal antibody technology 
started, followed with discovery of Fc receptors (FcR) with the generation in mice.  
            All these helped to get more information which made possible interesting studies 
in the basic mechanisms of AMI antibody-mediated immunity (Reichert and Pavlou, 
2004).  
            Antigen -specific immunity, like synthetic molecules, helped in activation of 
innate immunity system by stimulating (TLRs) T lymphocyte receptors, B cells, 
macrophages and dendritic cells. This activation, mediated after increasing Ag-specific 
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Abs (IgG and IgM), helps to trigger strong inflammation that in turn helps to protect 
body from bacterial, viral and parasitic infections (Pedras-Vasconcelos et al., 2006).  
Polyclonal and monoclonal reagents can be used either alone or mixed with 
antigens to increase or protect immune responses, malignant tumors and  infectious 
agents as well as to decrease harmful responses related with autoimmunity, 
inflammation and   hypersensitivity (Igietseme et al.,2004; Nicodemus et al.,2002; 
Stager et al., 2003).  The stable activated B cells perform important role in an 
independent homeostasis by generating IgM secreting cells (Agenes and Freitas, 1999). 
Use of passive Abs also increases the immunological protection against biological 
weapons. Passive antibodies can provide immediate immunity by stimulating antibody-
mediated immunity (AMI) against a biological agent (Buchwald and Pirofski, 2003; 
Casadevall, 2002). Continuous improvement of studies in technological fields of 
antibody-mediated immunity (AMI) and the demand of urgent therapies for new and 
emerging diseases helped the discovery of new Ab functions that have wide classical 
views of (AMI) antibody-mediated immunity. The B cell is the origin of the whole Ab 
molecule. In addition, the study of (AMI) antibody-mediated immunity has also come 
from studies with Ab fragments and antibody-derived peptides. 
T cells are the principal effector cells of specific cellular immunity and they 
have the ability to differentiate functionally to CD4+ cells which serve as helper cells 
and CD8+ cells which serve as cytotoxic cells (Sharma, 1999).   
The antibodies can act as positive and negative regulators of inflammation and 
(CMI) cell-mediated immunity. They have the ability to amplify or suppress the 
inflammatory response. Abs has anti-inflammatory effects which can be observed by 
intravenous injection of immunoglobulins for the treatment of inflammatory conditions 
(Bayry et al. 2003).  
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Immunoglobulin M (IgM) molecule has powerful activators of the complement 
system which is pro-inflammatory.  IgM has the property of early presence in the course 
of infection and defense against certain experimental bacterial and viral infections by 
amplifying the immune response (Casadevall and Pirofski, 2003). 
 
1.6 Classical views of antibody-mediated immunity (AMI) 
Antibody molecules have two domains, the antigen binding region which 
contains variable (V) region elements and a constant (C) region. The V region has 
binding ability to antigens with several forces such as hydrophobic, ionic, hydrogen 
bonds and Van der Waals interactions (Casadevall and Pirofski, 2004). 
The C region includes a fragment crystallizable (Fc) segment which determines 
the antibody's serotype and functional characteristics, such as its half-life in serum, 
ability to interact with FcR and complement activation. There is high capability of 
binding between Fc region and cellular receptors with some humoral components of the 
immune system such as the complement system. Ab functions as a junction bridge 
between a microbial antigen and the immune system (Casadevall and Pirofski, 2004). 
The function of specific Ab takes place in two types of actions, direct and indirect 
action: 
1- Direct or classical, such as virus neutralization and toxin, regarded as antimicrobial 
effect. Ab has ability to directly interact as bacteriostatic for example Escherichia coli 
lipopolysaccharide. In addition it has ability to interact directly with release of iron 
chelator, enterochelin. Antibodies are commonly used in therapeutics in eradicating 
bacteria (Fitzgerald and Rogers, 1980: Kozel et al., 2004). IgM and IgG antibodies have 
direct damaging action on the surface proteins of Borrelia burgdorferi which is very 
essential to protect microorganism from outer affections, leading to a bactericidal effect 
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in the absence of complement (Connolly and Benach, 2001; Connolly et al., 2004). 
Also, Ab binding can help to remove parasites in certain gut disorders and luminal 
parasites (Carlisle et al., 1991). 
2- Indirect activities need at least one more element of the immune system to interact 
with Ab such as opsonization and complement activation.  
        After development of a connection between Ab-mediated complement and Ab, 
activation results in opsonophagocytosis function for some microbes. Antigen can be 
eaten by a phagocytic cell after linking with an antibody, known as opsonin. 
        The best antibody in opsonin is IgG. The IgG antibody binding with Fc receptors 
on other types of cells, results in the activation of other functions (Kozel et al. 2004).  
        Another important mechanism is the activation of natural killer lymphocyte cells 
(NK), which act as cytotoxic and is antibody mediated against tumors and microbes. 
Passively, antibodies when transferred inside the body can neutralize and blocks inter 
virus infection (Haigwood et al., 2004: Kunkl et al., 1992). Antibody-mediated response 
has ability and power to restrict and define regions of each immunogen (Rhodin et al. 
2004). Systemic immunization consists of antigen coupling with Mab. This increases 
the number of Mab producing hybridomas against an antigen (Brady et al., 2000).  
 
1.7 Structure and production of immunoglobulin  
 
The antibodies are divided into five classes: IgD, IgA, IgM, IgE and IgG. Each 
antibody consists of a basic monomeric unit and four chains. These chains consist of 
two heavy and two light chains: Kappa (κ) light chains or Lambda (λ) light chains. The 
whole antibody consists of a (constant and variable) region.  
The fragment antigen binding (Fab) region of variable contains NH2 terminal 
end and the fragment crystallizable (Fc) constant contains COOH terminal end 
 
 
9 
 
(Schwartz, 1995). Each antibody variable end contains only one kind of antigen binding 
site. The fragment crystallizable (Fc) portion has the ability to identify class and binds 
with some cells which have FcR terminal.  
The FC receptors usually bind to plasma proteins cells (Kuppers et al., 1999). B 
cells have receptors on a special surface that best fit antigens involved in helping the 
multiplication (affinity maturation), providing a means whereby more specific 
antibodies with greater similarity can be produced (Schwartz, 1995).  
The most commonly found class is IgG (Myara et al., 1991). Any immunogen 
which induces an immune system response will result in the production of IgM and IgD 
iso-types which are situated on the B-cell surface as recognition receptors. Many of the 
immature cells produce low-affinity antibodies that bind to multiple antigens 
(Diamandis, E.P., 1996; Bouvet and Dighiero, 1998). 
Autoimmune reaction initiates the production of antibodies in normal sera in 
large quantity and shows alterations in specificity in different pathological situations 
when the immune system gets exposed. 
IgM, IgG, and IgA, natural antibodies contribute to the establishment and 
maintenance of immune memory especially when the immune system is exposed to 
pathogenic or physiological action like trauma or injury (Leslie and Martin, 1978; 
Rostenberg and Penaloza, 1978). 
            IgD antibody has the ability to regulate the protective response of IgG, IgM, and 
IgA isotypes which otherwise interfere with viral replication (Moskophidis et al., 1997).  
            Immunoglobulin E (IgE) has the ability to attach with plasma cell membrane of 
mast cell surfaces because they have many IgE receptors (FceR). High-affinity receptor 
for IgE (FcERI) is easily expressed on mast cells and basophils, which help cell 
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activation and immediate release of allergic mediators during parasitic infections 
(Molfetta et al., 2005; Metcalfe et al., 1997). 
        Activation of human mast cells through the high-affinity receptor for IgE (FceRI) 
underlies atopic allergic reactions (Okayama, 2000). These IgE molecules act 
specifically for helminthes which encourages mast cell binding to the parasite.  
         IgG immunoglobulins play a role of opsonin in phagocytosis, of Cryptococcus 
neoformans, by macrophages which   help phagocytic cells to eat (opsonate) antigen 
(Kozel and Mc Gaw, 1979).  
        Immunoglobulin E (IgE) is best known for such opsonitic activity because they 
mediate binding of mast cells to parasitic helminthes (Lukacs et al., 1996). IgE specific 
to Helicobacter pylori and Staphylococcus aureus has been reported in patients with 
peptic ulcers and topic dermatitis. However, IgG is not typically generated against other 
bacteria inspite of FceR availability (Aceti et al., 1991; Leung et al., 1993).   
        The class of each immunoglobulin is different from other serum proteins and 
depends on factors like, solubility in aqueous solution, isoelectric point, electrostatic 
density and the molecular size. These differences in characteristics help to isolate the 
immunoglobulin and fractionate it to different classes (Hudson and Hay, 1980).  
 
1.8 Immunogenicity for the production and standardization of antibodies 
      When an immune system has been exposed with an infection, natural antibodies 
created on, or exposure of the immune system with vaccination, immunogen helps to 
create a new antibody which can be used in diagnostics or for research and therapeutic 
purposes, the immunogen have the ability to raise polyclonal antibodies and fragments 
of monoclonal antibody with hybridoma cell lines (Abouzied et al., 1993; Skerritt et al., 
1996; Cheung et al., 2002; Korban et al., 2002; Darko et al., 2005).  
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         The quality of antibodies produced by immunization depends on the nature of the 
selected host, the quantity of the antigen administered per dose, the frequency of 
exposures of antigen and the time intervals between exposures (Emanuel et al., 2000; 
Doria-Rose et al., 2005). 
         Individual antigens have been used in immunization as immune complexes (IC) 
improved the enhancing of the immunogenic of soluble molecules and increase the 
number of monoclonal antibody (Mab) producing hybridomas against an antigen, and to 
elicit antibodies specific for poorly immunogenic epitopes (Brady et al., 2000).  
         Polyclonal anti-sera are a term used when the serum contains a collection of 
antibodies or when immunoglobulins are isolated from such sera (Leenars et al., 1999; 
Cachot et al., 1998: Akerstrom et al., 1985).  
         Polyclonal antibodies can be used in research and used in, immunoflourescence, 
immunohistochemistry and detection of antigens by ELISA, Western blots, 
immunoprecipitation procedures and immuno electron microscopy (Schipper et al., 
1991; Werner et al., 1996; You et al., 2002; Sasano et al., 2003). 
         Synthetic epitopes can be used to elicit anti-native protein antibodies, synthetic 
peptides have been used for producing Mabs and polyclonal anti bodies with the same 
or better affinity for proteins which generally observed for anti protein responses 
(Bahraoui et al., 1986; Laman et al., 1992).  
         The protein site of the antigen has the ability to connect with large molecules, like 
antibodies. The attraction between the antibody and antigen has been improved when 
the hydrophilic protein part is exposed (Westhof et al., 1984; Karplus and Schulz., 
1985; Fieser et al., 1987). 
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1.9 Cancer 
1.9.1 Tumor immunology 
          Tumor immunology deals with the study of immune response towards tumor and 
studies properties of the antigens of the tumor cells. In addition it includes a study of the 
immune response towards cancer cells, the immunogenic effects to the host and the 
changes of the immune system to identify and eradicate tumors. Any tumor to initiate an 
immunological response  must have characteristic antigens, any immunological 
approach to the treatment of cancer should be specific to destroy tumor cells only,  
while normal tissue should be unaffected (Castro, 1978). 
          Cancer immunology deals with the study of major advances in molecular and 
cellular immunology and determines the overall understanding of the complex and high 
rate of interactions between the immune system and tumor cells. The tumor–immune 
system interactions may act in a strong immune antitumor response or tolerance to 
tumor-associated antigens (Delgado, 2002).  
          Tumor cells have been shown to be carrying antigens on their surface which can 
be detected by the immune system in the tumor host. The immune system has the ability 
to recognize any changes in cell surface and responds to an abnormal change or to the 
formation of tumor cells.  
          Some cases lead to the escape of transformed cells from the immune system and 
it has been observed that it leads to the formation of malignant tumor. This lead to the 
opinion that the immune system is not effective enough to eradicate cancer. 
Advanced studies have demonstrated that the immune system cells can be increased in 
number to raise the immune sensitivity against the tumor disease and becomes a 
potential means of treatment (Ritz and Schlossman, 1982; Abbas and Lichtman, 2005). 
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1.9.2 The causes of cancer 
The cause of cancer may depend on the type of the cancer on the abnormal 
changes in gene regulations (Hall et al., 1998). The cause of cancer can be divided in 
several cases, like physical, chemical, environmental immune deficiencies, diet, drugs 
and gene mutation.  
There are several DNA sequence mutations as strong evidences, which cause 
cancer in human and mice (Watson et al., 2003). Chemical carcinogen causes mutations 
in proto-oncogene or tumor suppressor gene which helps abnormal growth of the 
mutated cells to transform and develop cancer cells (Weisburger and Williams, 1981). 
Some drugs also contain chemical agents that can lead to cancer death (Daly, 1993). 
Immune deficiencies also increase probability of malignancies (Bishop, 1999). 
 
1.9.3 Neoplasm 
Neoplasm is the term of ‘tumor’ translated accurately as swelling or a new 
abnormal growth in any part of the body which has some of similarity to its tissue of 
origin. Mass of abnormal tissue grows in a persistent fashion and its proliferation does 
not stop even after the removal of the causative agent (Paul, 1999).  
There are two types of neoplasms: malignant & benign. The common term for 
malignant tumor is cancer. Classification of human cancer depends on the molecular 
profile histological appearance which helps in diagnosis and treatment (Morris et al., 
1998; Mazzanti et al., 2004). 
 
 
 
 
 
 
14 
 
1.9.3.1 Malignant tumor 
            Malignant tumor or malignancy means uncontrollable anaplastic or dysplastic 
cells growth. This growth and invasion is usually carried out via direct lymphatic or 
haematogenic vessels (Cotran et al., 1999). Malignant tumor aggressively invades 
neighboring and/or adjacent tissues by diffusing in it and ultimately destroying it 
(Morris, et al., 1998). 
Tumor invades lymphatic tissues, nerves, vascular system and distant organ 
which is referred to as metastases. Cancer cells produce protease enzyme that affects 
membrane modification to escape through the adjacent cells (Morris, et al., 1998). 
Other evidence has shown that cancer is a heterogeneous disease (King, 2000). 
The formation of the cancer can be divided in two phases, premalignant and the staging 
process (Cotran et al., 1989).  
Mutation changes on the cancer cells include growth regulation gene, growth 
and morphology, antigen expression on the surface of the cancer cell, change in the 
enzyme level and hormones (Solomon et al., 1991; Fearon and Vogelstein, 1990). The 
exposure of radiation through ultraviolet sun light causes skin cancer and leads to 
inhibition of priming immune system during vaccination (Byrne et al., 2006).                                         
 
1.9.3.2 Benign tumor 
Benign tissue tumor is often encapsulated by variably thick fibrous tissue with a 
smooth external surface. Benign tumor has a slow growth and cells tend to be small, 
although some times are large (Morris et al., 1998; Mazzanti et al., 2004). 
 
 
 
 
 
15 
 
1.9.4 Epidemiology of cancer 
Epidemiology is the field of science that deals with the study, contribution of the 
distribution and determinants of a disease in human population in the world. Cancer 
expression varies in different malignant tumors that may be distinct mainly by their 
tumor site in the body e.g., colorectal, breast cancer, brain cancer and etc. or it some 
times depends on its histological type e.g., Kaposi’s sarcoma (McCredie and Coates, 
1998).  
Since immune system plays a role in tumor check it is thought that immune 
deficiency is one of the probable aggravating factors of malignancies. For example in 
AIDS patients, Kaposi’s sarcoma, central nervous system lymphoma and non 
Hodgkin’s lymphoma are recognized as AIDS- defining conditions (Bishop, 1999).  
 
1.9. 5 Cancer markers / immunity 
            Until now there is no single specific marker for tumor diseases. However, in the 
clinical management it is useful to use a number of tumor markers to aid diagnosis of 
malignant patients. Some of these markers are produced serologically from different 
hormones.  
         Others are produced by glands or by tissues from or turmeric organs. 
Bronchogenic carcinomas produce marker hormones such as (ACTH) adrinocortico 
trophic hormone, (PTH) parathyroid hormone, calcitonin and antidiuretic hormone. 
         Breast carcinomas produce prostaglandins which can be used as a marker. Some 
of these markers can be used clinically such as human chorionic gonadotrophin (HCG) 
and prostate specific antigen (PSA) which is mainly produced by choriocarcinoma and 
prostatic carcinoma. Gastrointestinal tumors also produce some type of proteins, which 
are only useful for predicting, prognosis and monitoring therapy. Pancreatic carcinomas 
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produce CA19-9 and DUPAN-2 while high serum levels of CA-125 are used to 
diagnose ovarian carcinomas. In the clinical settings, presence of urinary para proteins 
is suggestive of plasma cell myeloma ((Morris et al., 1998).  
 
1.10 Sodium dodecyl sulphate poly acrylamide gel electrophoresis (SDS-PAGE) 
Electrophoresis is the migration of charged molecules in solution in response to 
an electric field. Their rate of migration depends on the strength of the field; on  the net 
 charge, size and  shape of the  molecules  and  also  on  the  ionic strength, viscosity 
and temperature of the medium in which the molecules are moving. As an analytical 
instrument, electrophoresis is simple to use, rapid and highly sensitive (Rybicki and 
Purves, 1996). SDS-PAGE contains sodium dodecyl sulfate which acts as an anionic 
detergent which help to separate proteins in the cell fractions though polyacrylamide gel 
electrophoresis. The separation of protein is dependent on the molecular weight of their 
polypeptide chains (Shapiro et al., 1967).  
Separation of native proteins on polyacrylamide depends very strongly on the 
size of the molecules in addition to the charge (Ornstein, 1964). Sodium dodecyl sulfate 
(SDS), an anionic surfactant that is unusually used to act as hydrophobic binding 
environments of cell membranes, in addition help in denaturing process of some native 
state proteins (Xu and Keiderling, 2004). Several protein molecules have been shown to 
have binding with the dodecyl sulfate ions (Natarajan et al., 1999).  
Electrophoresis has become an essential technique for detecting and determining 
the molecular mass of some of the unknown proteins and characterization of proteins by 
western blot or mass spectrometry analysis (Sheen and Ali-Khan, 2005; Ikeda et al., 
1998).  
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These characteristics of polyacrylamide gel are used to separate most proteins 
and small oligo nucleotides that require a small gel pore size for retardation and 
separation of proteins and nucleic acids (Rybicki and Purves, 1996: Rybicki, E.P.2005). 
Proteins are amphoteric compounds. Their net charge is dependent on the pH of the 
medium in which they are suspended.  
A protein has a net negative charge when the pH solution has a higher isoelectric 
point and positively charged when the pH of the solution is below its isoelectric point. 
The protein net charge depends on the size of protein molecules which is different from 
protein to protein and under non-denaturing conditions the electrophoresis separation of 
proteins is limited by both size and charge of the molecules (Rybicki and Purves, 1996).  
 
1.11 Western blot 
Electroblotting has been a feature of a large number of laboratories and there are 
a large number of different apparatus around that can efficiently transfer proteins (or 
other macromolecules) from polyacrylamide gels to nitrocellulose sheets. Most of these, 
however, are based on the design of Towbin (Towbin et al., 1979). That is, they have 
vertical carbon / stainless steel / platinum electrodes in a large tank (Rybicki and 
Purves, 1996). Western blot is used in wide range and is very important in biologically 
orientated fields, because of ease of use, accurateness and ease of observation.  
Western blotting depends on combination of gel electrophoresis with the 
specificity of antibody detection. Sensitive direct immunoblotting assays are easy and 
can be rapidly implied methods for detection of antibody specificity using strips of 
nitrocellulose or polyvinylidene fluoride (PVDF) membranes (Radl et al., 1988; 
Boersma et al., 1989; Burry, 2000). 
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Immunocytochemistry has also been widely used for localization of    proteins in 
cells and tissue with antibodies. The connection between antibody and cell proteins 
depends on two independent criteria which are antibody specificity and type of method 
used. Parallel strip of electrophoresed protein extract on acrylamide gel can then be 
stained to expose the protein bands and matched up against the immunostain paper strip 
(Polak and Noorden, 1983).  
 
1.12 Immunochemistry staining 
           Immunochemistry staining includes immunocytochemistry and 
immunohistochemistry, the primary antibody mainly reacts to a specific antigen, 
combining sites which are known as fragment antigen binding (Fab) in cells or tissue of 
the antigen protein and not to other proteins (Itoh et al., 1977). 
           It is a technique in which an antibody reaction is raised against a specific tumor 
antigen on a histological tissue section and cells. This technique is widely used in tumor 
identification, diagnosis and classification. Antibodies labeled with fluorescent dyes 
conjugated with specific reagents such as horse reddish peroxidase (HRP) are used in 
situ to identify an antigen in tissue section (Polak and Noorden, 1983).  
           Histochemical and cytochemical techniques using immunoperoxidase and 
immunofluorescence staining technique which is use in histo and cytochemical in some 
cases provided additional criteria (Bosman and Kruseman, 1979). It is a useful and 
sensitive assay in detecting specific antigens, gene expression or gene amplification in 
tumors and normal tissues (Dickson and Lippman, 1995; Taylor, 1980). 
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1.13 Fundamentals of blood cell biology 
Immunology is the science to study the body immunity and explanation of the 
antibody behavior against any infection or any foreign substances that have entered any 
living body. The response of immune system includes several type of cells, an antigen 
when enter the body will stimulate the immune system and encounters special cells 
called antigen-presenting cells (APCs) the duty of these cells are to capture the foreign 
antigens.  
 The defense response, which occurs by such cells, is known as cell-mediated 
immunity. The remaining soluble macromolecules and proteins in the blood circulation 
as well as in extra-cellular fluid generate humororal response, thus known as 
constituents of humoral immunity (Parslow et al., 2001).  
Generally, antibodies are classified into three groups; IgM, IgG and IgA. Their 
concentration, specificity and isotype can effect or rather determine the action of an Ab. 
(Casadevall and Pirofski, 2003). Antibodies connect with specific antigens at suitable 
sites and not with other unrelated antigens. The attachment site, commonly known as 
fitting site, establishes the strength of connection between antibody and antigen (Roitt et 
al., 2006).  
Antibody applies in (IHC) immunohistochemistry as much as 
immunocytochemistry and it is applied in histopathology and cell biology. The 
fragments of antibodies can interact with the amino acids on the cell which form antigen 
(molecules) or binding site of the antibody (Gatter et al., 1985). 
           The function of immune system is to destroy any foreign substances in any body 
by direct killing with cytotoxic T cells or by the antibodies. Antibodies have ability for 
toxify, neutralize directly the venom, insects or snakes toxins bind these antigenic 
proteins or indirect by promotes the phagocytosis of these toxin by macrophages and 
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other phagocytes, furthermore antibodies have ability to neutralize the virus by blocking 
the protein receptors on the virus surface to prevent virus from connection with other 
cells. Antibodies can help the macrophages and phagocytes in opsonization and 
phagocyte the target by attachment with Fc receptors on the surface of these cells, after 
the Ab was coated the foreign body (Roitt et al., 2006).  
         IBMR3 is a monoclonal antibody of IgM isotype, produced in mice (Hara and 
Mat, 2004). All cell types in the immune system originate from the bone marrow. There 
are two main lineages that derive from the hemapoietic stem cell: (Hawkins et al., 
1992).  
 1- The lymphoid lineage 
         The lymphoid lineage consists of T lymphocyte (T cells), B lymphocyte (B cells) 
and natural killer cells (NK cells). The B cell has a membrane-bound immunoglobulin 
as a receptor by which it has the ability binding with antigens, and every Ig on an 
individual B cell has one specificity (Hunt, 2007). 
2. The myeloid lineage 
         The myeloid lineage consists of monocytes, macrophages Langerhans cells, 
dendritic cells and megakaryocytes and the type of granulocytes which includes 
(eosinophils, neutrophils and basophils). Hematopoiesis can be seen summarized in the 
schematic over view as below in figure 1.2. 
 
 
 
 
 
 
 
21 
 
 
 
Figure 1.2: Schematic overview of hematopoiesis, emphasizing the erythroid and 
lymphoid pathways 
[Adapted from; Parslow et al. 2001] 
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1.14 Objectives of the study 
         To determine and investigate the expression profile of the IBMR3 antigens in 
different tissues and organs of Balb/c mouse, rat and cancer cell line HT29 in addition 
to mouse fibroblast 3T3 using immunoblotting technique through expression profiling 
by molecular weight (MW), peak height and raw volume. 
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CHAPTER 2 
MATERIALS AND METHODS 
 
2.1 Media preparations 
2.1.1 RPMI 1640 medium 
        The RPMI-1640 medium (Rosswell Park Memorial Institute) mix (Hiclone, USA) was 
developed by Moore et al., (1967). RPMI 1640 powder contained 2.05mM L-glutamine 
without sodium bicarbonate (A Perstorp Life Sciences Company). It was dissolved in 
deionized water to make a final volume of 1 L (Ultra PUM 1.8.2 MΩ-CM). 
        The medium was first dissolved in 800 ml of deionized water. 2.0 g/ L sodium 
bicarbonate was added to this solution. The medium was then passed through a filter paper 
to exclude undissolved materials.  
        This step was followed by addition of 1% (10 ml) penicillin-streptomycin solution. 
Fetal bovine serum (FBS) (Hyclone, USA) was thawed at room temperature and then 
heated in water bath at 56ºC for 30 minutes. 
        This was followed by addition of the 10% F.B.S. v/v (100 ml) to medium and then 
deionized water was added to make up 1000 ml as the final volume of medium. This 
prepared medium was sterilized by passing through a 0.22μm filter (NALGENE Company, 
USA) using vacuum pump in 10-20 minutes. The prepared medium container was then 
sealed and kept at 4ºC until use. 
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2.1.2 Dulbecco’s Modified Eagle’s Medium (DMEM) 
       The medium was prepared by mixing 13.65 gram Dulbecco’s Modification of Eagle’s 
Medium (DMEM) (Sigma) with 500 ml of distilled water mixed with magnetic stirrer, and 
was followed by adding sodium bicarbonate. 
       The medium was then filtered through sterilized filter with diameter of 0.22µm 
(NALGENE Company, USA), and was kept at 4°C. In order to make a complete medium, 
heat inactivated fetal bovine serum (HyClone, USA) was added to a final concentration of 
10% v/v. The medium was kept at 4°C.  
 
2.2 Staining preparation 
2.2.1 Coomassie blue stain 
Preparation 
        7 ml of acetic acid was added to 40 ml methanol, and then 53 ml of distilled water 
were added, mixed well and then 0.2 gm Coomassi blue powder stain added and the 
reagents were mixed and filtered using a whatman paper and store at room temperature. 
 
2.2.2 Ponceau S stain  
Preparation  
         Ponceau S stain was prepared by dissolving 0.1g of stain powder in 100 ml of 1% 
acetic acid. 
 
 2.2.3 Methods of haematoxylin staining 
         After drying the slide section at room temperature overnight, the slides (3-4-µm 
thickness) were fixed in cold methanol for 10 minutes, and washed with running water for 
